| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$21 |
Change in substantial holding
|
14 Jul 2025 9:27AM |
$0.030 |
$0.011 |
fallen by
63.33%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$745 |
Update - Notification of buy-back - RF1
|
14 Jul 2025 9:25AM |
$2.980 |
$3.570 |
risen by
19.80%
|
|
| Mighty Kingdom Limited (MKL) ORDINARY FULLY PAID |
Communication Services |
- |
Update - Consolidation/Split - MKL
|
14 Jul 2025 9:25AM |
$0.026 |
$0.165 |
risen by
534.62%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$182 |
Notice under section 708A(5)(e) of the Corporations Act
|
14 Jul 2025 9:24AM |
$1.805 |
$1.180 |
fallen by
34.63%
|
|
| Polynovo Limited (PNV) ORDINARY FULLY PAID |
Health Care |
$826 |
Special briefing with Professor Toby Coates
|
14 Jul 2025 9:24AM |
$1.140 |
$1.195 |
risen by
4.82%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,158 |
Update - Notification of buy-back - GNC
|
14 Jul 2025 9:23AM |
$7.570 |
$5.210 |
fallen by
31.18%
|
|
| GBM Resources Limited (GBZ) ORDINARY FULLY PAID |
Materials |
$131 |
Tranche 1 Payment Received on up to $3.2m Mt Morgan Sale
|
14 Jul 2025 9:23AM |
$0.019 |
$0.029 |
risen by
52.63%
|
|
GBZ - Price-sensitive ASX Announcement
Full Release
Key Points
- GBM Resources Limited received Tranche 1 Payment (~$3.2 million) for the sale of the Mt Morgan Project.
- The payment is part of a total $20 million sale agreement with Smartset Services Pty Ltd, a subsidiary of Lighthouse Minerals Limited.
- Further payments under the agreement remain conditional upon satisfaction of specific milestones.
- The funds will support working capital and progression of GBM’s gold projects in Queensland.
- GBM continues to focus on value creation and business development opportunities in the region.
- The transaction demonstrates GBM’s strategic approach to leveraging its asset portfolio.
- GBM acknowledges support from shareholders and stakeholders during the transaction process.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peak Minerals Limited (PUA) ORDINARY FULLY PAID |
Materials |
- |
Change in substantial holding
|
14 Jul 2025 9:21AM |
$0.051 |
$0.049 |
fallen by
3.92%
|
|
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$9 |
ODA Awarded SaaS Contracts with Transport Providers
|
14 Jul 2025 9:21AM |
$0.065 |
$0.047 |
fallen by
27.69%
|
|
ODA - Price-sensitive ASX Announcement
Full Release
Key Points
- Orcoda Limited has secured new SaaS contracts with transport providers.
- The contracts involve implementation of Orcoda's proprietary technology for transport management.
- These SaaS agreements are expected to increase the company’s recurring revenue.
- The contracts signal Orcoda’s growth and presence in the transport and logistics industry.
- The announcement reaffirms Orcoda’s commitment to digital solutions and operational efficiency for its clients.
- The company continues to expand its client base and market reach through technology-driven offerings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fat Prophets Global Contrarian Fund Limited (FPC) ORDINARY FULLY PAID |
Financials |
$41 |
Update - Notification of buy-back - FPC
|
14 Jul 2025 9:21AM |
$1.085 |
$1.470 |
risen by
35.48%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$671 |
Net Tangible Asset Backing
|
14 Jul 2025 9:21AM |
$2.340 |
$2.080 |
fallen by
11.11%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$109 |
Response to ASX Price Query
|
14 Jul 2025 9:21AM |
$0.015 |
$0.010 |
fallen by
33.33%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Alterity Therapeutics responded to an ASX price and volume query.
- The company is not aware of any undisclosed information that could explain the recent trading activity.
- Alterity Therapeutics is in compliance with ASX Listing Rules and continuous disclosure obligations.
- The company provided an update on its operations and ongoing clinical trials.
- Alterity Therapeutics confirmed it has provided all necessary information to the ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$77 |
IONIC TECH SECURES GBP 11M FOR UK SUPPLY CHAIN INITIATIVE
|
14 Jul 2025 9:20AM |
$0.017 |
$0.340 |
risen by
1,900%
|
|
IXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Ionic Rare Earths Limited (IXR), via its subsidiary IonicTech, received GBP 11 million from UK Research and Innovation.
- The grant will support the construction of a commercial rare earth separation and recycling plant in Belfast, UK.
- The project is aligned with the UK Government’s strategy to strengthen domestic supply chains of critical minerals.
- IonicTech’s technology allows recycling of end-of-life permanent magnets and recovery of high-purity rare earth oxides.
- The initiative addresses supply chain vulnerabilities in the electric vehicle and renewable energy sectors.
- Funding enables IonicTech to scale up operations and process both mined and recycled feedstocks.
- The project aims to provide the UK with sustainable, secure, and independent rare earth supply capabilities.
- The announcement demonstrates IXR's growing role in the circular economy for critical minerals.
- The plant is expected to be operational by 2026, with ongoing research, development, and commercialisation activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Dirt Resources Limited (GR8) ORDINARY FULLY PAID |
Materials |
$39 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
14 Jul 2025 9:20AM |
$0.100 |
$0.800 |
risen by
700%
|
|
GR8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers period ending 31 March 2023.
- Exploration activities focused on gold and lithium projects.
- Drilling and sampling programs advanced at key tenements.
- Positive assay results reported from exploration programs.
- No mining production or development activities undertaken this quarter.
- Cash outflows were mainly attributed to exploration and evaluation costs.
- No receipts from product sales during the reporting period.
- Company ended the quarter with a specific cash position.
- No substantial changes in tenement holdings or ownership.
- Corporate updates included board and management changes.
- Capital raisings and share placements detailed in the period.
- Appendix 5B provides detailed cash flow statements and compliance disclosures.
- Company confirmed ongoing compliance with ASX Listing Rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KMD Brands Limited (KMD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$94 |
KMD ASX Listing Rule 1.15.3
|
14 Jul 2025 9:19AM |
$0.235 |
$0.052 |
fallen by
77.87%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$10 |
Serpentine Project Farm-Out Presentation
|
14 Jul 2025 9:19AM |
$0.045 |
$0.037 |
fallen by
17.78%
|
|
| Astute Metals NL (ASE) ORDINARY FULLY PAID |
Materials |
- |
Change of Share Registry and Registered Address
|
14 Jul 2025 9:19AM |
$0.022 |
$0.017 |
fallen by
25%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$182 |
Notification regarding unquoted securities - AVH
|
14 Jul 2025 9:17AM |
$1.805 |
$1.180 |
fallen by
34.63%
|
|
| Vinyl Group Ltd (VNL) ORDINARY FULLY PAID |
Information Technology |
$112 |
Final Director's Interest Notices
|
14 Jul 2025 9:17AM |
$0.115 |
$0.078 |
fallen by
32.17%
|
|
| Matsa Resources Limited (MAT) ORDINARY FULLY PAID |
Materials |
$83 |
Devon Pit Gold Mine Update
|
14 Jul 2025 9:16AM |
$0.066 |
$0.085 |
risen by
28.79%
|
|
MAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Mining operations commenced at Devon Pit Gold Mine within the Lake Carey Gold Project.
- Key mining and haulage contracts have been secured to support the project.
- Ore processing arrangements finalized with a third-party processing plant.
- Mobilization of mining equipment and workforce completed as scheduled.
- Production timelines and gold recovery forecasts provided, with initial gold pour expected soon.
- Financial projections and project economics discussed, indicating positive cash flow potential.
- Regulatory approvals and environmental compliance obligations have been met.
- Risk management and safety strategies implemented to support operations.
- Community engagement and local stakeholder consultations are ongoing.
- Project milestones achieved include site preparation, commencement of mining, and shipment of ore.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The a2 Milk Company Limited (A2M) ORDINARY FULLY PAID |
Consumer Staple |
$4,447 |
Notification of cessation of securities - A2M
|
14 Jul 2025 9:15AM |
$7.290 |
$6.130 |
fallen by
15.91%
|
|
| New World Resources Limited (NWC) ORDINARY FULLY PAID |
Materials |
- |
Third Supplementary Bidder's Statement
|
14 Jul 2025 9:14AM |
$0.066 |
$0.067 |
risen by
1.52%
|
|
NWC - Price-sensitive ASX Announcement
Full Release
Key Points
- The document is the Third Supplementary Bidder's Statement for NWC Acquisitions Pty Ltd's takeover offer for New World Resources Limited.
- It provides important updates and supplements to the original and previous Bidder’s Statements.
- The offer period for the takeover has been extended, with revised dates specified.
- Clarifies tax implications for accepting NWC shareholders, including potential capital gains tax consequences.
- Outlines the latest responses and recommendations from the board of NWC regarding the offer.
- Explains the process and steps for shareholders to accept the offer.
- Provides updates on regulatory approvals relevant to the takeover.
- Describes bid conditions, including minimum acceptance levels and other regulatory conditions.
- Reaffirms the bidder’s intentions for NWC if the takeover is successful, including operational and board changes.
- Highlights key risks and considerations for shareholders in deciding whether to accept the offer.
- Summarizes the rationale behind the takeover offer and perceived benefits for NWC shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| City Chic Collective Limited (CCX) ORDINARY FULLY PAID |
Consumer Discretionary |
$19 |
Trading Update for FY25 Year End
|
14 Jul 2025 9:14AM |
$0.086 |
$0.049 |
fallen by
43.02%
|
|
CCX - Price-sensitive ASX Announcement
Full Release
Key Points
- City Chic Collective Limited (CCX) provided a trading update for the 2025 financial year.
- The company is continuing its strategic repositioning in the global plus-size women's apparel market.
- Total sales for the 48 weeks to 9 June 2024 were $194.1 million, down 17% compared to the prior period.
- Comparable sales for the same period were down 5% year-on-year.
- Online sales accounted for approximately 68% of total sales.
- Gross margin improved by 5 percentage points compared to the prior year, reflecting better inventory management and cost controls.
- EBITDA for the 48-week period was $8.5 million, a significant improvement from the $26.2 million loss in the previous corresponding period.
- The company reduced its inventory by $27.8 million year-on-year and remains committed to further reductions.
- City Chic’s store network consists of 54 stores in Australia and New Zealand after closing underperforming locations.
- The company is focused on further cost reductions and operational efficiencies.
- Trading conditions remain challenging, especially in the wider retail sector.
- The Board is continuing to review all strategic options to deliver shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Harvey Norman Holdings Ltd (HVN) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,482 |
Change of Director's Interest Notice
|
14 Jul 2025 9:14AM |
$5.510 |
$4.400 |
fallen by
20.15%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$137 |
Final Nyrada Phase I Clinical Trial Cohort to Commence
|
14 Jul 2025 9:14AM |
$0.270 |
$0.560 |
risen by
107.41%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Nyrada Inc has commenced the final cohort in its Phase I clinical trial of NYR-866.
- NYR-866 is a cholesterol-lowering drug candidate.
- The trial is designed to assess safety, tolerability, and pharmacokinetics in healthy volunteers.
- Earlier cohorts showed NYR-866 is well-tolerated without serious adverse events.
- The final cohort involves a higher dose of NYR-866.
- Full study results are expected in Q3 2024.
- Positive results may lead to a Phase II trial in patients with elevated cholesterol.
- Nyrada highlights a significant unmet need for new cholesterol-lowering therapies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
